Your browser doesn't support javascript.
loading
Genomic characterization of MDR/XDR-TB in Kazakhstan by a combination of high-throughput methods predominantly shows the ongoing transmission of L2/Beijing 94-32 central Asian/Russian clusters.
Klotoe, B J; Kacimi, S; Costa-Conceicão, E; Gomes, H M; Barcellos, R B; Panaiotov, S; Haj Slimene, D; Sikhayeva, N; Sengstake, S; Schuitema, A R; Akhalaia, M; Alenova, A; Zholdybayeva, E; Tarlykov, P; Anthony, R; Refrégier, G; Sola, C.
Afiliação
  • Klotoe BJ; Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay, 91198, Gif-sur-Yvette cedex, France.
  • Kacimi S; Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay, 91198, Gif-sur-Yvette cedex, France.
  • Costa-Conceicão E; Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay, 91198, Gif-sur-Yvette cedex, France.
  • Gomes HM; Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay, 91198, Gif-sur-Yvette cedex, France.
  • Barcellos RB; Laboratory of Molecular Biology Applied to Mycobacteria, FIOCRUZ, Rio de Janeiro, Brazil.
  • Panaiotov S; Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay, 91198, Gif-sur-Yvette cedex, France.
  • Haj Slimene D; Center of Scientific and Technological Development (CDCT), Secretary of Health of Rio Grande do Sul State (SES/RS), Porto Alegre, Brazil.
  • Sikhayeva N; Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay, 91198, Gif-sur-Yvette cedex, France.
  • Sengstake S; National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria.
  • Schuitema AR; Institute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay, 91198, Gif-sur-Yvette cedex, France.
  • Akhalaia M; Institut Pasteur de Tunisie, Tunis, Tunisie.
  • Alenova A; National Centre for Biotechnology, Astana, Kazakhstan.
  • Zholdybayeva E; Royal Tropical Institute (KIT), Amsterdam, The Netherlands.
  • Tarlykov P; Royal Tropical Institute (KIT), Amsterdam, The Netherlands.
  • Anthony R; Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.
  • Refrégier G; National Centre for Tuberculosis Problems, Almaty, Kazakhstan.
  • Sola C; National Centre for Biotechnology, Astana, Kazakhstan.
BMC Infect Dis ; 19(1): 553, 2019 Jun 24.
Article em En | MEDLINE | ID: mdl-31234780
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Farmacorresistência Bacteriana Múltipla / Mycobacterium tuberculosis Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Male / Middle aged País/Região como assunto: Asia / Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Farmacorresistência Bacteriana Múltipla / Mycobacterium tuberculosis Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Male / Middle aged País/Região como assunto: Asia / Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article